Copyright
©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 634-646
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.634
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.634
Table 1 Baseline clinical parameters in examined patients (mean ± SE or %)
Lactulose group | Rifaximin group | EcN group | P value1 | |
Age, yr | 48.92 ± 1.64 | 49.07 ± 1.76 | 48.85 ± 1.93 | 0.996 |
Male, % (n) | 78.6 (11) | 78.6 (11) | 71.4 (10) | 0.877 |
Etiology of cirrhosis | ||||
HCV, % (n) | 57.1 (8) | 42.9 (6) | 50.0 (7) | 0.940 |
Alcoholism, % (n) | 21.4 (3) | 35.7 (5) | 28.6 (4) | |
Mixed, % (n) | 21.4 (3) | 21.4 (3) | 21.4 (3) | |
Cirrhosis duration, years | 8.14 ± 0.61 | 8.00 ± 0.61 | 8.07 ± 0.60 | 0.986 |
Time to progression from hepatitis to cirrhosis, years | 4.00 ± 0.41 | 3.42 ± 0.38 | 3.56 ± 0.32 | 0.468 |
Child-pugh score | ||||
A, % (n) | 35.7 (5) | 42.9 (6) | 28.6 (4) | 0.733 |
B, % (n) | 64.3 (9) | 57.1 (8) | 71.4 (10) | |
HE grade | ||||
MHE, % (n) | 42.9 (6) | 35.7 (5) | 42.9 (6) | 0.979 |
Grade 1, % (n) | 35.7 (5) | 35.7 (5) | 28.6 (4) | |
Grade 2, % (n) | 21.4 (3) | 28.6 (4) | 28.6 (4) |
- Citation: Manzhalii E, Moyseyenko V, Kondratiuk V, Molochek N, Falalyeyeva T, Kobyliak N. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. World J Hepatol 2022; 14(3): 634-646
- URL: https://www.wjgnet.com/1948-5182/full/v14/i3/634.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i3.634